Maximum tolerated is not maximum approved
Weight reduction in the long programmes flattens at roughly sixty to seventy-two weeks. The timing is consistent, predictable and almost never mentioned in advance.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Weight reduction in the long programmes flattens at roughly sixty to seventy-two weeks. The timing is consistent, predictable and almost never mentioned in advance.
Where the curve flattens, what flattens with it, and what does not.
The clinical effect profile is almost fully predictable from where the receptor is expressed, which is unusual and useful.
What adding GIP activity does, on the current evidence, and what remains unresolved.
Two withdrawal-design trials tell us what happens when treatment stops. Neither tells us what the lowest effective maintenance dose is.
The central effects are not a bonus. On the current evidence they are the principal mechanism of weight loss.
Where the curve flattens, what flattens with it, and what does not.
What the trials measured was continuation against withdrawal. What patients want to know is continuation at a lower dose, and that study has largely not been done.
The ceiling varies severalfold between people, and nothing measurable at baseline predicts where it sits.
The graduation interval differs between barrel sizes, and a 1 mL barrel is frequently marked in two-unit steps. Reading one as though it were marked in single units halves…
Rapid weight loss by any means raises gallstone risk. Separating that from a direct drug effect requires a comparator, and the trials have one.
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
We give background rates alongside trial rates, because an event occurring during treatment is not thereby caused by it.
This piece takes the measurement apart into the decisions it is made of, because each decision moves the answer.
The ceiling in this class is anatomical: the same receptor populations that suppress appetite provoke nausea, and they saturate together.
Dead space in the needle hub is a real and calculable loss, and it matters more at small volumes than anybody expects.
The intervention with the clearest evidence is the one nobody frames as an intervention: adjusting the dose.
The intervention with the clearest evidence is the one nobody frames as an intervention: adjusting the dose.
We looked at what the dose-ranging data supports about going higher, and it is thinner and less flattering than the market assumes.
System suitability is the set of checks demonstrating that the instrument and method were performing adequately when your sample was injected. It is recorded as a matter of…